International Journal of Cancer Management

Published by: Kowsar

A Comparative Study of FIGO 1988 Versus 2009 Staging for Endometrial Carcinoma

Ali Emre Tahaoglu 1 , * , Sait Bakir 2 , Emre Erdogdu 2 and Cem Dane 3
Authors Information
1 Department of Obstetrics and Gynecology, Gazi Yasargil Research and Training Hospital, Elazig Yolu 12, Km Diyarbakir, Turkey
2 Diyarbakir Obstetrics and Gynecology Hospital, Baglar-Diyarbakir, Turkey
3 Haseki Research and Training Hospital, Istanbul, Turkey
Article information
  • Iranian Journal of Cancer Prevention: January 2017, 10 (1); e4986
  • Published Online: January 21, 2017
  • Article Type: Research Article
  • Received: December 7, 2015
  • Revised: February 29, 2016
  • Accepted: January 3, 2017
  • DOI: 10.17795/ijcp-4986

To Cite: Emre Tahaoglu A, Bakir S, Erdogdu E, Dane C. A Comparative Study of FIGO 1988 Versus 2009 Staging for Endometrial Carcinoma, Int J Cancer Manag. 2017 ; 10(1):e4986. doi: 10.17795/ijcp-4986.

Copyright © 2017, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods
3. Results
4. Discussion
  • 1. Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008; 101(2): 205-10[DOI][PubMed]
  • 2. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105(2): 103-4[PubMed]
  • 3. Petru E, Luck HJ, Stuart G, Gaffney D, Millan D, Vergote I, et al. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol. 2009; 143(2): 69-74[DOI][PubMed]
  • 4. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, et al. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2010; 116(5): 1141-9[DOI][PubMed]
  • 5. Cooke EW, Pappas L, Gaffney DK. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer. 2011; 117(18): 4231-7[DOI][PubMed]
  • 6. Kato T, Watari H, Endo D, Mitamura T, Odagiri T, Konno Y, et al. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system. J Surg Oncol. 2012; 106(8): 938-41[DOI][PubMed]
  • 7. Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Gynecol Oncol. 2012; 125(1): 103-8[DOI][PubMed]
  • 8. Koskas M, Chabbert-Buffet N, Bendifallah S, Luton D, Clavel-Chapelon F, Rouzier R. Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort. Int J Gynecol Cancer. 2012; 22(3): 447-51[DOI][PubMed]
  • 9. Koskas M, Rouzier R. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 2011; 117(5): 1225-6[DOI][PubMed]
  • 10. Gultekin M, Yildiz F, Ozyigit G, Beyaz H, Hayran M, Kose F, et al. Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma. Med Oncol. 2012; 29(4): 2955-62[DOI][PubMed]
  • 11. Abu-Rustum NR, Zhou Q, Iasonos A, Alektiar KM, Leitao MM Jr, Chi DS, et al. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer. 2011; 21(3): 511-6[DOI][PubMed]
  • 12. Astec Study Group , Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009; 373(9658): 125-36[DOI][PubMed]
  • 13. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16): 3668-75[DOI][PubMed]
  • 14. Solhjem MC, Petersen IA, Haddock MG. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys. 2005; 62(5): 1379-84[DOI][PubMed]
  • 15. Boronow RC. Endometrial cancer and surgical staging: a personal assessment. Philipp J Obstet Gynecol. 1998; 22(3): 71-7[PubMed]
  • 16. Horowitz NS, Peters WA 3rd, Smith MR, Drescher CW, Atwood M, Mate TP. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol. 2002; 99(2): 235-40[PubMed]
  • 17. Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, Podratz KC. Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol. 2004; 92(3): 833-8[DOI][PubMed]
  • 18. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol. 2001; 81(2): 273-8[DOI][PubMed]
  • 19. Aristizabal P, Graesslin O, Barranger E, Clavel-Chapelon F, Haddad B, Luton D, et al. A suggested modification to FIGO stage I endometrial cancer. Gynecol Oncol. 2014; 133(2): 192-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments